John C. Hoefs

6.8k total citations · 2 hit papers
73 papers, 5.2k citations indexed

About

John C. Hoefs is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, John C. Hoefs has authored 73 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hepatology, 48 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in John C. Hoefs's work include Liver Disease Diagnosis and Treatment (48 papers), Liver Disease and Transplantation (34 papers) and Hepatitis C virus research (22 papers). John C. Hoefs is often cited by papers focused on Liver Disease Diagnosis and Treatment (48 papers), Liver Disease and Transplantation (34 papers) and Hepatitis C virus research (22 papers). John C. Hoefs collaborates with scholars based in United States, Germany and Canada. John C. Hoefs's co-authors include Bruce A. Runyon, Mitchell L. Shiffman, Timothy R. Morgan, Janice K. Albrecht, Stuart C. Gordon, Christian Trépo, Antonio Craxı̀, Vinod K. Rustgi, Rafael Esteban and Gary L. Davis and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and American Journal of Clinical Nutrition.

In The Last Decade

John C. Hoefs

72 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

1998 1.1k citations Gary L. Davis, Rafael Esteban et al. New England Journal of Medicine profile →
A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C

2001 507 citations Karen L. Lindsay, Christian Trépo et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John C. Hoefs United States	30	3.8k	3.5k	848	381	381	73	5.2k
Lennox J. Jeffers United States	41	6.4k 1.7×	6.4k 1.9×	1.1k 1.3×	738 1.9×	327 0.9×	136	8.3k
Pierluigi Toniutto Italy	35	2.7k 0.7×	2.6k 0.7×	938 1.1×	189 0.5×	301 0.8×	179	4.2k
J. De Groote Belgium	24	4.5k 1.2×	4.4k 1.3×	941 1.1×	176 0.5×	642 1.7×	71	6.4k
Jaw‐Ching Wu Taiwan	38	3.3k 0.9×	3.0k 0.9×	549 0.6×	570 1.5×	370 1.0×	145	4.9k
V. Di Marco Italy	54	5.7k 1.5×	7.0k 2.0×	770 0.9×	343 0.9×	395 1.0×	274	8.4k
Savino Bruno Italy	38	5.9k 1.5×	5.7k 1.6×	508 0.6×	625 1.6×	325 0.9×	133	7.0k
Luigi Elio Adinolfi Italy	43	3.8k 1.0×	4.5k 1.3×	547 0.6×	305 0.8×	633 1.7×	139	6.4k
Thierry Poynard France	43	4.2k 1.1×	4.5k 1.3×	1.2k 1.5×	192 0.5×	331 0.9×	143	6.2k
Margaret F. Bassendine United Kingdom	44	5.6k 1.5×	4.8k 1.4×	987 1.2×	296 0.8×	569 1.5×	120	7.4k
Akihiro Matsumoto Japan	37	3.1k 0.8×	3.3k 1.0×	576 0.7×	353 0.9×	370 1.0×	132	4.4k

Countries citing papers authored by John C. Hoefs

Since Specialization

Citations

This map shows the geographic impact of John C. Hoefs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Hoefs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Hoefs more than expected).

Fields of papers citing papers by John C. Hoefs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Hoefs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Hoefs. The network helps show where John C. Hoefs may publish in the future.

Co-authorship network of co-authors of John C. Hoefs

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Hoefs. A scholar is included among the top collaborators of John C. Hoefs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Hoefs. John C. Hoefs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morgan, Timothy R., Kathryn Osann, Teodoro Bottiglieri, et al.. (2015). A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP. Cancer Prevention Research. 8(9). 864–872. 15 indexed citations

Everson, Gregory T., Mitchell L. Shiffman, John C. Hoefs, et al.. (2011). Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology. 55(4). 1019–1029. 52 indexed citations

Sterling, Richard K., Elizabeth C. Wright, Timothy R. Morgan, et al.. (2011). Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C. The American Journal of Gastroenterology. 107(1). 64–74. 90 indexed citations

Hoefs, John C., Mitchell L. Shiffman, Zachary Goodman, et al.. (2011). Rate of Progression of Hepatic Fibrosis in Patients With Chronic Hepatitis C: Results From the HALT-C Trial. Gastroenterology. 141(3). 900–908.e2. 29 indexed citations

Xia, Victor W., Mehrtash Hashemzadeh, David K. Imagawa, et al.. (2010). The Clinical Presentation of Chronic Hepatitis B Virus Infection in Asian Americans. Journal of Clinical Gastroenterology. 44(5). 364–370. 10 indexed citations

Shiffman, Mitchell L., Chihiro Morishima, Jules L. Dienstag, et al.. (2009). Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial. Gastroenterology. 137(6). 1986–1994. 30 indexed citations

Lok, Anna S., Richard K. Sterling, James E. Everhart, et al.. (2009). Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma. Gastroenterology. 138(2). 493–502. 429 indexed citations

Hoefs, John C., et al.. (2006). Noninvasive Evaluation of Liver Disease Severity. Clinics in Liver Disease. 10(3). 535–562. 6 indexed citations

Hoefs, John C., et al.. (2006). Treatment of Chronic HCV Infection in Special Populations. International Journal of Medical Sciences. 3(2). 69–74. 10 indexed citations

10.

Zell, Jason A., et al.. (2004). Precore mutant hepatitis B reactivation after treatment with CHOP???rituximab. Anti-Cancer Drugs. 16(1). 83–85. 15 indexed citations

11.

Lindsay, Karen L., Christian Trépo, Tobias Heintges, et al.. (2001). A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C. Hepatology. 34(2). 395–403. 507 indexed citations breakdown →

12.

Davis, Gary L., Rafael Esteban, Vinod K. Rustgi, et al.. (1998). Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C. New England Journal of Medicine. 339(21). 1493–1499. 1070 indexed citations breakdown →

13.

Tong, Myron J., K. Rajender Reddy, Paul J. Pockros, et al.. (1997). Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial. Hepatology. 26(3). 747–754. 148 indexed citations

14.

Hoefs, John C., et al.. (1995). Perfused Kupffer cell mass. Digestive Diseases and Sciences. 40(3). 552–560. 15 indexed citations

15.

Horne, D.W., et al.. (1993). 5-Methyltetrahydrofolate transport in basolateral membrane vesicles from human liver. American Journal of Clinical Nutrition. 58(1). 80–84. 47 indexed citations

16.

Said, Hamid M., et al.. (1992). Biotin transport in human liver basolateral membrane vesicles: A carrier-mediated, Na+ gradient-dependent process. Gastroenterology. 102(6). 2120–2125. 18 indexed citations

17.

Hoefs, John C., et al.. (1992). Diagnostic paracentesis.. PubMed. 37. 391–409. 5 indexed citations

18.

Hoefs, John C.. (1992). Globulin Correction of the Albumin Gradient: Correlation With Measured Serum to Ascites Colloid Osmotic Pressure Gradients. Hepatology. 16(2). 396–403. 20 indexed citations

19.

Rector, William G., John C. Hoefs, Kenneth F. Hossack, & Gregory T. Everson. (1988). Hepatofugal portal flow in cirrhosis: Observations on hepatic hemodynamics and the nature of the arterioportal communications. Hepatology. 8(1). 16–20. 46 indexed citations

20.

Runyon, Bruce A., John C. Hoefs, & Timothy R. Morgan. (1988). Ascitic fluid analysis in malignancy-related ascites. Hepatology. 8(5). 1104–1109. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact